Clinical Trial Update: A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Synchrony Dual Optic Intraocular Lens in Patients Undergoing Cataract Extraction [Phase 3]

View source ↗

Summary

A Phase 3 multicenter study evaluating the Synchrony Dual Optic Intraocular Lens for cataract patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Synchrony Dual Optic Intraocular Lens

Snippet

Sponsor: Abbott Medical Optics | Conditions: Cataract | Phase 3 | Status: TERMINATED